Ovarian steroids and serotonin neural function

Molecular Neurobiology

Volumn 18, Issue 2, 1998, Pages 87-123

  Bethea, C L ^a,b   Pecins Thompson, M ^a,b   Schutzer, W E ^a,b   Gundlah, C ^a,b   Lu, Z N ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Afferent circuits; Afferent neurons; Efferent circuits; Estrogen; Ovarian steroids; Progestin; Serotonin neural function; Target neurons

Indexed keywords

ARTICLE; BRAIN REGION; COGNITION; ESTROGEN ACTIVITY; HUMAN; MOOD; NONHUMAN; PROGESTERONE METABOLISM; SEROTONINERGIC NERVE; TARGET CELL;

EID: 0032434187     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02914268     Document Type: Article

References (280)

1. Albinsson A., Palazidou E., Stephenson J., and Andersson G. (1994) Involvement of the 5HT2 receptor in the 5HT receptor-mediated stimulation of prolactin release. Enr. J. Pliarinacol. 251, 157-161.
2. Alves S. E., Weiland N. G., Hastings N. B., Tanapat P., and McEwen B. S. (1997) Estradiol regulation of 5HT neurons in the dorsal raphe of the rat differs from the monkey: an analysis of tryptophan hydroxylase mRNA levels. Soc. Neurosci. 23,1222, Abstract 484.1.
3. Alves S. E., Weiland N. G., Hayashi S., and McEwen B. S. (1996) Immunocytochemical (ICC) localization of nuclear progestin receptors (PR) and estrogen receptors (ER) within the rat dorsal raphe nucleus (DRN). Soc. Neurosci. 22, 618, Abstract 246.17.
4. Artigas F., Ferez V., and Alvarez E. (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psych. 51,248-251.
5. Attali G., Weizman A., Gil-Ad I., and Rehavi M. (1997) Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res. 756,153-159.
6. Avis N. E., Brambilla D., McKinlay S. M., and Vass K. (1994) A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann. Epidemiol. 4,214-220.
7. Azmitia E. C. and Cannon P. J. (1986) The primate serotonergic system: a review of human and animal studies and a report on Macaca fascicularis. Adv. Neural. 43,407-468.
8. Bach A. W. J., Lan N. C., Johnson S. L., et al. (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sei. USA 85,4934-4938.
9. Bagdy G. (1996) Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav. Brain Res. 73,277-280.
10. Bagdy G. and Makara G. B. (1994) Hypothalamic paraventricular nucleus lesions differentially affect serotonin-lA (5HT-1A) and 5HT2 receptor agonist-induced oxytocin, prolactin and corticosterone responses. Endocrinology 143, 1127-1131.
11. Bagdy G. and Makara G. B. (1995) Paraventricular nucleus controls 5HT2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses. Enr. J. Pliannacol. 275, 301-305.
12. Bancroft J., Cook A., Davidson D., Bennie J., and Goodwin G. (1991) Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol. Med. 21,305-312.
13. Barker E. L. and Blakely R. D. (1995) Norepinephrine and serotonin transporters. Molecular targets of antidepressant drugs, in PsychopJmrinacology: The
14. Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds.) Raven, New York, pp. 321-333.
15. Bayliss D. A., Seroogy K. B., and Millhorn D. E. (1991) Distribution and regulation by estrogen of progesterone receptor in hypothalamus of the cat. Endocrinology 128,2610-2617.
16. Behzadi G., Kaien P., Parvopassu R, and Wiklund L. (1990) Afférents to the median raphe nucleus of the rat: retrograde cholera toxin and wheat germ conjugated horseradish peroxidase tracing, and selective [3H]-aspartate labelling of possible excitatory amino acid inputs. Neuroscience 37, 77-100.
17. Beitz A. J. (1982) The sites of origin of brain stem neurotensin and serotonin projections to the .. ' rodent nucleus raphe magnus. J. Neurosci. 2, 829-843.
18. Beitz A. J. (1990) Relationship of glutamate and aspartate to the periaqueductal gray-raphe magnus projection: analysis using immunocytochemistry and microdialysis. J. Histocliem. Cytochem. 38,1755-1765.
19. Berridge C. W., Arnsten A. F., and Foote S. L. (1993) Noradrenergic modulation of cognitive function: clinical implications of anatomical, electrophysiological and behavioral studies in animal models. Psychol. Med. 23,557-564.
20. Bethea C. L. (1993) Colocalization of progestin receptors with serotonin in raphe neurons of macaque. Neuroendocrinology 57,1-6.
21. Bethea C. L. (1994) Regulation of progestin receptors in raphe neurons of steroid-treated monkeys. Neuroendocrinology 60,50-61.
22. Bethea C. L., Brown N. A., and Kohama S. G. (1996) Steroid regulation of estrogen and progestin receptor messenger ribonucleic acid in monkey hypothalamus and pituitary. Endocrinology 137, 4372-4383.
23. Bethea C. L., Fahrenbach W. H., Sprangers S. A., and Freesh F. (1992) Immunocytochemical localization of progestin receptors in monkey hypothalamus: effect of estrogen and progestin. Endocrinology 130,895-905.
24. Bethea C. L., Hess D. L., Widmann A. A., and Henningfield J. M. (1995) Effect of progesterone on prolactin, hypothalmic B-endorphin, hypothalamic substance P, and midbrain serotonin in guinea pigs. Neuroendocrinology, 61, 695-703.
25. Bethea C. L., Kohama S. G., and Pecins-Thompson M. (1996) Pituitary and brain actions of estrogen and progesterone in the regulation of primate prolactin secretion, in Estrogens, Progestins and
26. Their Antagonists, vol 2 (Pavlik E. J., ed.), Birkhauser, Boston, pp. 3-46.
27. Bialy M. and Kaczmarek L. (1996) c-Fos expression as a tool to search for the neurobiological base of the sexual behaviour of males. Ada Neurobiol. Exp. 56,567-577.
28. Biegon A. and McEwen B. S. (1982) Modulation by estradiol of serotonin receptors in brain. J. Nenrosci. 2,199-205.
29. Biegon A., Fischette C. T., Rainbow T. C, and McEwen B. C. (1982) Serotonin receptor modulation by estrogen in discrete brain nuclei. Nenroendocrinology 35,287-291.
30. Biegon A., Reches A., Snyder L., and McEwen B. S. (1983) Serotonergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sei. 32,2015-2021.
31. Bitar M. S., Ota M., Linnoila M., and Shapiro B. H. (1991) Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats. Psychoneiiroendocrinology 16,547-557.
32. Biver F., Lotstra F., Nomclus M., et al. (1996) Sex difference in 5HT2 receptor in the living human brain. Neitwsci. Lett 204,25-28.
33. Blakely R. D., De Felice L. J., and Hartzell H. C. (1994) Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol. 196, 236-281.
34. Blaustein J. D. and Turcotte J. C. (1989) Estradiolinduced progestin receptor immunoreactivity is found only in estrogen receptor-immunoreactive cells in guinea pig brain. Neiiroendocrinology 49, 454-461.
35. Blum I., Vered Y., Lifshitz A., et al. (1996) The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal \vomen. Isr. J. Mod. Sei. 32,1158-1162.
36. Bohmaker K., Eison A. S., Yocca F. D., and Mellar E. (1993) Comparative effects of chronic 8-OHDPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5HT1A autoreceptors. Nenropliariiiacology 32,527-534.
37. Bourque C. W., Oliet S. H., and Richard D. (1994) Osmoreceptors, osmoreception, and osmoregulation. Frontiers Neuroendocriiwl. 15,231-274.
38. Bradley P. B., Engel G., Feniuk W., Fozard J. R., Humphrey P. P. A., and Middlemiss D. N. (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neurophnrmacologist 25,563-576.
39. Brown T. J., MacLusky N. J., Leranth C., Shanabrough M., and Naftolin F. (1990) Progestin
40. receptor-containing cells in guinea pig hypothalamus: afferent connections, morphological characteristics, and neurotransmitter content. Mol. Cell. Ncitrosci. 1, 58-77.
41. Burnet P. W. J., Eastwood K. L., and Harrison P. J. (1995) The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res. 676, 157-168.
42. Carlsson M. and Carlsson A. (1988) A regional study of sex differences in rat brain serotonin. Prog. NeiiropsyclwphariiincoL Biol. Psychiatry 12, 53-61.
43. Cavazos J. E., Wang C. J., Sitoh Y. Y, Ng S. E., and Tien R. D. (1997) Anatomy and pathology of the septal region. Neiiroiwnging Clin. North Am. 7, 67-78.
44. Celada P., Perez J., Alvarez E., and Artigas R (1992) Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients \vith major depression: relationship to clinical improvement. J. Clin. Psychopliarinacol. 12, 309-315.
45. Chalmers D. T. and Watson S. J. (1991) Comparative anatomical distribution of 5HT1A receptor mRNA and 5HT1A binding in rat brain-a combined in situ hybridization/in vitro receptor autoradiographic study. Brain Res. 561,51-60.
46. Chevillard C., Barden N., and Saavedra J. M. (1981) Estradiol treatment decreases type A and increases type B monoamine oxidase in specific brain stem areas and cerebellum of ovariectomized rats. Brain Res. 222,177-181.
47. Chugani D. C., Muzik O., Chakraborty P., Mangner T., and Chugani H. T. (1998) Human brain serotonin synthesis capacity measured in vivo with alpha-[c-11] methyl-L-tryptophan. Synapse 28, 33-43.
48. Clarke C. L. (1990) Cell-specific regulation of progesterone receptor in the female reproductive system. Mol. Cell. Endocrinol. 70, C29-C33.
49. Clarke W. P. and Goldfarb J. (1989) Estrogen enhances a 5HT1A response in hippocampal slices from female rats. Eitr. J. Phanuacol. 160, 195-197.
50. Clarke W. P. and Maayani S. (1990) Estrogen effects on 5HT1A receptors in hippocampal membranes from ovariectomized rats: functional and binding studies. Brain Res. 518,287-291.
51. Clarkson T. B., Cline J. M., Williams J. K., and Anthony M. S. (1997) Gonadal hormone substitutes: effects on the cardiovascular system. Osteoporosis Int. 7 (Suppl. 1), 43-51.
52. Coccaro E. F., Kavoussi R. J., Oakes M., Cooper T. B., and Hauger R. (1996) 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects. Psychopliarmacology 126,24-30.
53. Cohen I. R. and Wise P. M. (1988) Effects of estradiol on the diurnal rhythm of serotonin activity in microdissected brain areas of ovariectomized rats. Endocrinology 122,2619-2625.
54. Cone R. I., Davis G. S., and Goy R. W. (1981) Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Res. Bull. 7, 639-644.
55. Couse J. R, Lindzey J., Grandien K., Gustrafsson JA., and Korach K. S. (1997) Tissue distribution and quantitative analysis of estrogen receptor-a (ERa) and estrogen receptor-ß (ERß) messenger ribonucleic acid in the wild-type and ERcc-knockout mouse. Endocrinology 138,4613-4621.
56. Crawley J. N., Glowa J. R., Majewska M. D., and Paul S. M. (1986) Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398,382-385.
57. Cry M., Bosse R., and DiPaolo T. (1996) Modulation of frontal cortex 5HT2 serotonin receptors in ovariectomized rats: A model of CNS change occuring at menopause. Soc. Neurosci. 22, 1776, Abstract 698.11.
58. de Lignieres B. and Vincens M. (1982) Differential effects of exogenous oestradiol and progesterone on mood in post-menopausal women: individual dose/effect relationship. Maturitas 4, 67-72.
59. de Montigny C, Blier P., and Chaput Y. (1984) Electrophysiologically-identified serotonin receptors in the rat CNS. Effect of antidepressant treatment. Neuropliannacology 23,1511-1520.
60. Dennerstein L. (1996) Well being, symptoms and the menopausal transition. Maturitas 23,147-157.
61. Descarries L., Watkins K. C., Garcia S., and Beaudet A. (1982) The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radiographie study. J. Coiup. Neural. 207, 239-254.
62. Desmond N. L. and Levy W. B. (1997) Ovarian steroidal control of connectivity in the female hippocampus: an overview of recent experimental findings and speculations on its functional consequences. Hippocampus 7,239-245.
63. Di Paolo T., Daigle M., Picard V., and Barden N. (1983) Effect of acute and chronic 17ß estradiol treatment on serotonin and 5-hydroxyindole
64. acetic acid content of discrete brain nuclei of ovariectomized rat. Exp. Brain Res. 51, 73-76.
65. Dijcks R. A., Couvée J. H., and Ruigt G. S. (1994) Long-term in vivo desipramine or estrogen treatment fails to affect serotonin-induced outward current in hippocampal pyramidal cells of the rat. Neuroscience, 60,213-215.
66. Dillon K. A., Gross-Isseroff R., Israeli M., and Biegen A. (1991) Autoradiographic analysis of serotonin 5HT1A receptor binding in the human brain postmortem: effects of age and alcohol. Brain Res. 554,56-64.
67. DonCarlos L. L., Greene G. L., and Morrell J. I. (1989) Estrogen plus progesterone increases progestin receptor immunoreactivity in the brain of ovariectomized guinea pigs. Neiiroendocrinology 50,613-623.
68. Dumas S., Darmon M. C., Delort J., and Mallet J. (1989) Differential control of tryptophan hydroxylase expression in raphe and in pineal gland: Evidence for a role of translation efficiency. J. Nenrosci. 24,537-547.
69. Ellenbogen M. A., Young S. M., Dean P., Palmour R. M., and Benkelfat C. (1996) Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Nenropsychopharmncology 15,465-474.
70. Eriksson E., Ailing C., Andersch B., Andersson K., and Berggren U. (1994) Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome. Neiiropsychop.Iianttacology 11, 201-213.
71. Eriksson E., Hedberg M. A., Andersch B., and Sundblad C. (1995) The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neitropsychopharinacology 12,167-176.
72. Fabre-Nys C., Blache D., Hinton M. R., Goode J. A., and Kendrick K. M. (1994) Microdialysis measurement of neurochemical changes in the mediobasal hypothalmus of ovariectomized ewes during oestrus. Brain Res. 649,282-296.
73. Farmer C. J., Isakson T. R., Coy D. J., and Renner K. J. (1996) In vivo evidence for progesterone dependent decreases in serotonin release in the hypothalamus and midbrain central grey: relation to the induction of lordosis. Brain Res. 711,84-92.
74. Feiten D. L. and Sladek J. R. (1983) Monamine distribution in primate brain V. Monaminergic nuclei; anatomy, pathways and local organization. Brain Res. Bull. 10,171-284.
75. Fifa E. and Pillion G. (1992) 5-hydroxytryptamine receptors. Pharnmcol. Rev. 44,401-458.
76. Fink G. and Summer B. E. H. (1996) Oestrogen and mental state. Nature 383,306.
77. Fischette C. T., Biegon A., and McEwen B. S. (1983) Sex differences in serotonin 1 receptor binding in rat brain. Science 222,333-335.
78. Flores G., Wood G. K., Liang J. J., Quirion R., and Srivastava L. K. (1996) Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex. J. Nenrosci. 16, 7366-7375.
79. Fox S. R., Harlan R. E., Shivers B. D., and Pfaff D. W. (1990) Chemical characterization of neuroendocrine targets for progesterone in the female rat brain and pituitary. Neiiroendocrinology 51, 276-283.
80. Frankfurt M., Renner K., Azmitia E., and Luine V. (1985) Intrahypothalamic 5, 7-dihydroxytryptamine: temporal analysis of effects on 5-hydroxytryptamine content in brain nuclei and on facilitated lordosis behavior. Brain Res. 340, 127-133.
81. Fuller R. W. and Wong D. T. (1990) Serotonin uptake and serotonin uptake inhibition. Ann. NY Acnd. Sei. 600, 68-80.
82. Gereau R. W., IV, Kedzie K. A., and Renner K. J. (1993) Effect of progesterone on serotonin turnover in rats primed with estrogen implants into the ventromedial hypothalamus. Brain Res. Bull. 32,293-300.
83. Gitlin M. J. and Pasnau R. O. (1989) Psychiatric syndromes linked to reproductive function in women: a review of current knowledge. Am. J. Psychiatry 146,1413-1422.
84. Glaser J. H., Rubin B. S., and Barfield R. J. (1983) Onset of the receptive and preceptive components of feminine sexual behavior in rats following the intravenous administration of progesterone. Hon. Behav. 17,18-27.
85. Gonzalo-Ruiz A., Liberman A. R. and SanzAnquela J. M. (1995) Organization of serotoninergic projections from the raphe nuclei to the anterior thalamic nuclei in the rat: a combined retrograde tracing and 5HT immunohistochemical study. J. Cliem. Neuroanat. 8,103-115.
86. Goodwin G. M. (1996) How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs. J. Clin. Psych. 57,9-13.
87. Goodwin G. M., DeSouza R. J., Green A. R., and Heal D. J. (1987) The pharmacology of the behavioural and hypothermie responses of rats to 8-hydroxy-2-(di-;;-propylamino) tetralin (8-OHDPAT). Psychopharmacology 91,506-511.
88. Gordon F. T. and Soliman M. R. (1996) The effects of estradiol and progesterone on pain sensitivity and brain opioid receptors in ovariectomized rats. Harm. Behav. 30,244-250.
89. Graeff F. G., Guimaraes F. S., De Andrade T. G., and Deakin J. F. (1996) Role of 5HT in stress, anxiety and depression. Plmnnacol. Bioclicin. Belmv. 54, 129-141.
90. Greene G. L., Harris K., Bova R., Kinders R., Moore B., and Nolan C. (1988) Purification of T47D human progesterone receptor and immunochemical characterization with monoclonal antibodies. Mol. Endocrinol. 2, 714-726.
91. Greene G. L., Sharma V., and Cheng L. (1996) Estrogen receptor structure and function in breast cancer cells, in General Molars Accomplishments in Cancer Research (Fortner J. G. and Sharp P. A., eds.), Lippincott, Philadelphia, p. 147-156.
92. Greene G. L., Sobel N. B., King W. J., and Jensen E. V. (1984) Immunochemical studies of estrogen receptors. J. Steroid Biochem. 20,51-56.
93. Grégoire A. J. P., Kumar R., Everitt B., Henderson A. R, and Studd J. W. W. (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347,930-933.
94. Gross-Isserof R. and Biegon A. (1988) Autoradiographic analysis of [3H]-imipramine binding in the human brain postmortem: effects of age and alcohol. J. Neurocliem. 51,528-534.
95. Gross-Isseroff R., Israeli M., and Biegon A. (1988) Autoradiographic analysis of [3H] desmethylimipramine binding in the human brain postmortem. Brain Res. 456,120-126.
96. Gross-Isseroff R., Israeli M., and Biegon A. (1989) Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch. Gen. Psychiatry 46,237-241.
97. Gundlah C., Simon L. D., and Auerbach S. B. (1998) Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study. Brain Res. 785,91-96.
98. Halbreich U. and Tworek H. (1993) Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int. J. Psychiatry Med. 23,1-27.
99. Halbreich U., Petty F., Yonkers K., Kramer G. L., Rush A. J., and Bibi K. W. (1996) Low plasma yaminobutyric acid levels during the late luteal
100. phase of women with premenstrual dysphoric disorder. Am. J. Psychiatry 153, 718-720.
101. Halbreich U., Rojansky N., Palter S., Tworek H., Hissin P., and Wang K. (1995) Estrogen augments serotonergic activity in postmenopausal women. Biol. Psychiatry 37,434-441.
102. Halbreich U., Rojansky N., Zander K.}., and Barkai A. (1991) Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects. J. Psychiat. Res. 25, 7-18.
103. Halliday G., Harding A., and Paxinos G. (1995) Serotonin and tachykinin systems, in The Rat Nervous System, (Paxinos G., ed.), Academic, New York, pp. 929-974.
104. Heils A., Teufel A., Pétri S., et al. (1995) Functional promoter and polyadenylation site mapping of the human serotonin (5HT) transporter gene. J. Neural. Transm. 102, 247-254.
105. Hery M, Laplante E., and Kordon C. (1976) Participation of serotonin in the phasic release of LH. I. Evidence from pharmacological experiments. Endocrinology 99,496-500.
106. Hoffman B. J. and Mezey E. (1989) Distribution of 5HT1C receptor mRNA in adult rat brain. FEES Lett. 247,453-462.
107. Holst J., Backstrom T., Hammerback S., et al. (1989) Progestin addition during oestrogen replacement therapy-effects on vasomotor symptoms and mood. Maturitas 11,13-20.
108. Houk J. C. (1997) On the role of the cerebellum and basal ganglia in cognitive signal processing. Prog. Brain Res. 114,543-552.
109. Hoyer D. and Martin G. (1997) 5-HT receptor classification and nonemclature: towards a harmonization with the human genome. Neiiropharmacology 36,419-428.
110. Hoyer D., Clarke D. E., Fozard J. R., et al. (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Plmrinncol. Rev. 46,157-203.
111. Hoyer D., Pazos A., Probst A., and Palacios J. M. (1986) Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5HT1A recognition sites. Apparent absence of 5HT1B recognition sites. Brain Res. 376,85-96.
112. Jorgensen H., Knigge U., and Warberg J. (1992) Involvement of 5HT1, 5HT2 and 5HT3 receptors in mediation of the prolactin response to serotonin and 5-hydroxytryptophan. Neiiroendocrinology 55,336-343.
113. Jergensen H., Knigge U., and Warberg J. (1993) Effect of serotonin receptor agonists on prolactin secretion in male rats. Neurocndocrinology 57, 401-407.
114. Jacobs B. L. and Azmitia E. C. (1992) Structure and function of the brain serotonin system. Physiol. Rev. 72 165-231.
115. James M. D., Hole D. R., and Wilson C. A. (1989) Differential involvement of 5-hydroxytryptamine (5HT) in specific hypothalamic areas in the mediation of steroid-induced changes in gonadotropin release and sexual behavior in female rats. Nenroendocrinology 49,561-569.
116. Johnson M. D. and Crowley W. R. (1983) Acute effects of estradiol on circulating luteinizing hormone and prolactin concentrations and on serotonin turnover in individual brain nuclei. y Endocrinology 113,1935-1941.
117. Juorio A. V., Greenshaw A. J., and Boulton A. A. (1986) Effects of acute and chronic phenelzine on regional monoamine metabolism in rats and its potentiation by deuterium substitution. NaunynSchnieidebergs Arch. Pharmacol. 333,240-245.
118. Katzenellenbogen B. S. (1996) Estrogen receptors: bioactivities and interactions with cell signaling .pathways. Biol. Reprod. 54, 287-293.
119. Katzenellenbogen J. A., O'Malley B. W., and Katzenellenbogen B. S. (1996) Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the celland promoter-specific action of these hormones. Mol. Endocrinol. 10,119-131.
120. Kawaguchi Y. (1997) Neostriatal cell subtypes and their functional roles Ncnrosci. Res. 27,1-8. -
121. King T. S., Steger R. W., and Morgan W. W. (1986) Effect of ovarian steroids to stimulate region-specific hypothalamic 5-hydroxytryptamine synthesis in ovariectomized rats. Nenroendocrinology 42, 344-350.
122. Kitzman P. H. and Bishop G. A. (1994) The origin of serotoninergic afférents to the cat's cerebellar nuclei. J. Comp. Neural 340,541-550.
123. Koler C. and Steinbusch H. (1982) Identification of serotonin and non-serotonin containing neurons of the midbrain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain. Neuroscience 7,951-975.
124. Kuiper G. G. J. M., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J-A. (1996) Cloning of a novel estrogen receptor expressed in rat prostate. Proc. Natl. Acad. Sei. USA 93,5925-5930.
125. Kursar J. D., Nelson D. L., Wainscott D. B., Cohen M. L., and Baez M. (1992) Molecular cloning, functional expression and pharmacological characterization of a novel serotonin receptor (5hydroxytrypfamine 2F) from rat stomach fundus. Mol. Pharmacol. 42,549-557.
126. Lacau-Mengido I. M., Libertun C., and Becu-Villalobos D. (1996) Different serotonin receptor subtypes participate in 5-hydroxytryptophaninduced gonadotropins and prolactin release in the female infantile rat. Neurocndocrinology 63, 415-421.
127. Ladisich W. (1974) Effect of progesterone on regional 5-hydroxytryptamine metabolism in the rat brain. Neiiropharmacology 13,877-883.
128. Lakoski J. M. (1988) Estrogen-induced modulation of serotonin 5HT1A mediated responses in the dorsal raphe nucleus (DRN). Plinnnacologist 30, A126. (Abstract).
129. Leibenluft E., Fiero P. L., and Rubinow D. R. (1994) Effects of the menstrual cycle on dependent variables in mood disorder research. Aral. Gen. Psychiatry 51, 761-781.
130. Leranth C., MacLusky N. J., Brown T.}., Chen E. C., Redmond D. E., Jr., and Naftolin F. (1992) Transmitter content and afferent connections of estrogen-sensitive progestin receptor-containing neurons in the primate hypothalamus. Neurocndocrinology 55, 667-682.
131. Lippert T. H., Filshie M., Muck A. O., Seeger H., and Zvvirner M. (1996) Serotonin metabolite excretion after postmenopausal estradiol therapy. Matnritas 24,37-41.
132. Loric S., Launay J. M., Colas J. F., and Maroteaux L. (1992) New mouse 5HT-2 like receptor. Expression in brain heart and intestine. FEES Lett. 312, 203-207.
133. Lovenberg T. W., Baron B. M., de Lecea L., et al. (1993) A novel adenylyl cyclase-activating serotonin receptor (5HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11, 449-458.
134. Luque J. M., Bleuel Z., Hendrickson A., and Richards J. G. (1996) Detection of MAO-A and MAO-B mRNAs in monkey brainstem by crosshybridization with human oligonucleotide probes. Mol. Brain Res. 36,357-360.
135. Majewska M. D. (1992) Neurosteroids: Endogenous bimodal modulators of the GABA-A receptor. Mechanism of action and physiological significance, in Progress in Nenrobiology, Pergamon, Great Britain, p. 379-395.
136. Majewska M. D., Ford-Rice E, and Falkay G. (1989) Pregnancy-induced alterations of GABA-A receptor sensitivity in maternal brain: an
137. antecedent of post-partum blues? Brain Res. 482,397-401.
138. Mani S. K., Allen J. M, Lydon J. P., et al. (1996) Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol. Endocrinol 10,1728-1737.
139. Maricq A. V., Peterson A. S., Brake A. J., Myers R. M., and Julius D. (1991) Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. Science 254, 254-255.
140. Martinez-Gomez M., Cruz Y., Salas M., Hudson R., and Pacheco P. (1994) Assessing pain threshold in the rat: changes \vith estrus and time of day. Physiol. Bebau. 55,651-657.
141. Mason P. (1997) Physiological identification of pontomedullary serotonergic neurons in the rat. J. Neiirophysiol. 77,1087-1098.
142. Mason P. and Leung C. G. (1996) Physiological functions of pontomedullary raphe and medial reticular neruons. Prog. Brain Res. 107,269-282.
143. Maswood S., Andrade M., Caldarola-Pastuszka M., and Uphouse L. (1996) Protective actions of the 5HT2A/2C receptor agonist, DOI, on 5-HT1A receptor-mediated inhibition of lordosis behavior. Neiiropharmacology 35,497-501.
144. Maswood S., Stevvart G., and Uphouse L. (1995) Gender and estrous cycle effects of the 5HT1A agonist, 8-OH-DPAT, on hypothalamic serotonin. Pharmacol. Biochem. Behav. 51,807-813.
145. Matthews-Felton T., Corodimas K. P., Rosenblatt J. S., and Morrell J. I. (1995) Lateral habenula neurons are necessary for the hormonal onset of maternal behavior and for the display of postpartum estrus in naturally parturient female rats. Behav. Neurosci. 109,1172-1188.
146. McEwen B. S. (1991) Non-genomic and genomic effects of steroids on neural activity. TIPS 12, 141-147.
147. McKay L. I. and Cidlowski J. A. (1998) Cross-talk between nuclear factor-KB and the steroid hormone receptors: mechanisms of mutual antagonism. Mol. Endocrinol. 12,45-56.
148. McKenna K. F., Baker G. B., Coutts R. T., and Greenshaw A. J. (1992) Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines and alpha 2-adrenoreceptor function. J. Pharm. Sei. 81,832-835.
149. McKinley M. J., Pennington G. L., and Oldfield B. J. (1996) Anteroventral wall of the third ventricle and dorsal lamina terminalis headquarters for
150. control of body fluid homeostasis? Clin. Exp. Pharinacol Physiol. 23,271-281.
151. McQueen J. K., Wilson H., and Fink G. (1997) Estradiol-17ß increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Mol. Brain Res. 45,13-23.
152. Medina V. M., Davvson-Basoa M. E., and Gintzler A. R. (1993) 17 beta-estradiol and progesterone positively modulate spinal cord dynorphin: relevance to the analgesia of pregnancy. Nenroendocrinology 58,310-305.
153. Mendelson S. D., McKittrick C. R., and McEwen B. S. (1993) Autoradiographic analysis of the effects of estradiol benzoate on [3H]-paroxetine binding in the cerebral cortex and dorsal hippocampus of gonadectomized male and female rats. Brain Res. 601,299-302.
154. Meyer D. C., Singh J., and Jiminez A. E. (1983) Uptake of serotonin and norepinephrine in hypothalamic and limbic brain regions during the estrous cycle and the effect of neurotoxic lesions on estrous cyclicity. Brain Res. Bull. 10, 639-645.
155. Miyagawa K., Rosch J., Stanczyk R, and Hermsmeyer K. (1997a) Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nature Med. 3,324-327.
156. Miyagawa K., Vidgoff J. and Hermsmeyer K. (1997b) Ca2+ release mechanism of primate drug-induced coronary vasospasm. Ain. J. Physiol. 272, H2645-2654.
157. Molineaux S. M., Jessell T. M., Axel R., and Julius D. (1989) 5HT1C receptor is a prominent serotonin receptor subtype in the central nervious system. Proc. Natl. Acad. Sei. USA 86,6793-6797.
158. Morissette M., Levesque D., Belanger A., and Di Paolo T. (1990) A physiological dose of estradiol with progesterone affects striatum biogenic amines. Can. J. Plnjsiol. Pharmacol. 68,1520-1526.
159. Morrell J. L, Schwanzel-Fukuda M., Fahrbach S. E., and Pfaff D. W. (1984) Axonal projections and peptide content of steroid hormone concentrating neurons. Peptides 5, 227-239.
160. Mortola J. F. (1994) A risk-benefit appraisal of drugs used in the management of premenstrual syndrome. Drug Safety 10,160-169.
161. Mortola J. R, Girton L., and Yen S. C. S. (1989) Depressive episodes in premenstrual syndrome. Am. J. Obstet. Gynecol. 161,1682-1687.
162. Nishizawa S., Benkelfat C., Young S. N., et al. (1997) Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sei. USA 94,4823-4824.
163. Nomura M., Ueta Y., Larsen P. J., et al. (1997) Water deprivation increases the expression of pituitary adenylate cyclase-activating polypeptide gene in the rat subfornical organ. Endocrinology 138, 4096-4100.
164. O'Keane V. and Dinan T. G. (1991) Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am. J. Psychiatry 148,1009-1015.
165. O'Keane V., O'Hanlon M., Webb M., and Dinan T. (1991) d-Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration. Clin. Endocrinol. 34, 289-292.
166. Oppenheim G. (1983) Estrogen in the treatment of depression: neuropharmacological mechanisms. Biol. Psychiatry 18, 721-725.
167. Orchinik M. and McEwen B. (1993) Novel and classical actions of neuroactive steroids. Res. Biochem. Inc. IX, 1-6.
168. Ortega-Corona B. G., Valencia-Sanchez A., KubliGarfias C, et al. (1994) Hypothalamic monoamine oxidase activity in ovariectomized rats after sexual behavior restoration. Arch. Med. Res. 25, 337-340.
169. Osborne N. N. and Hamon M. (1988) Neuronal Serotonin. Wiley, New York.
170. Owens M. J. and Nemeroff C. B. (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin. Chem. 40, 288-295.
171. Pare D. and Llinas R. (1995) Conscious and pre-conscious processes as seen from the standpoint of sleep-waking cycle neurophysiology. Neuropsychologia 33,1155-1168.
172. Parry B. L. (1997) Psychobiology of premenstrual dysphoric disorder. Semin. Reprod. Endocrinol. 15, 55-68.
173. Paul S. M., Rehavi M., Skolnick P., et al. (1984) High affinity binding of antidepressants to biogenic amine transport sites in human brain and platelet: studies in depression, in Neurobiology of Mood Disorders, (Post R. M. and Ballenger J. C. eds.), Williams and Wilkins, Baltimore, MD, pp. 846-853.
174. Pazos A., Probst A., and Palacios J. M. (1987) Serotonin receptors in the human brain-Ill. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21,97-122.
175. Pearlstein T. B. (1995) Hormones and depression: what are the facts about premenstrual syndrome,
176. menopause and hormone replacement therapy? Am. J. Obstet. Gynecol. 173,646-653.
177. Pecins-Thompson M. and Bethea C. L. (1997) RU 486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys. Nenroendocrinology 65,335-343.
178. Pecins-Thompson M. and Bethea C. L. (1998b) Ovarian steroid regulation of 5HT1A autoreceptor messenger ribonucleic acid expression in the dorsal raphe of rhesus macaques. Neuroscience, 89,267-277.
179. Pecins-Thompson M., Brown N. A., and Bethea C. L. (1998a) Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Mol. Brain Res. 53,120-129.
180. Pecins-Thompson M., Brown N. A., Kohama S. G., and Bethea C. L. (1996) Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J. Neurosci. 16, 7021-7029.
181. Peroutka S. J. (1994) Molecular biology of serotonin (5HT) receptors. Synapse 18,241-260.
182. Pfaff D. W., Gerlach J. L., McEwen B. S., Ferin M., Carmel P., and Zimmerman E. A. (1976) Autoradiographic localization of hormone-concentrating cells in the brain of the female rhesus monkey. J. Comp. Nenrol. 170,279-294.
183. Pfaus J. G., Kleopoulos S. P., Mobbs C. V., Gibbs R. B., and Pfaff D. W. (1993) Sexual stimulation activates c-fos within estrogen-concentrating regions of the female rat forebrain. Brain Res. 624, 253-267.
184. Press M. F. and Greene G. L. (1988) Localization of progesterone receptor with monoclonal antibodies to the human progestin receptor. Endocrinology 122,1165-1175.
185. Purvis C. C. and Duncan M. J. (1997) Discrete thalamic lesions attenuate winter adaptations and increase body weight. Am. J. Pliysiol 273, R226-R235.
186. Rapkin A. J., Morgan M., Goldman L., Brann D. W., Simone D., and Mahesh V. B. (1997) Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet. Gynecol. 90, 709-714.
187. Rehavi M., Sepcuti H., and Weizman A. (1987) Upregulation of imipramine binding and serotonin uptake by estradiol in female rat brain. Brain Res. 410,135-139.
188. Reiman E. M., Lane R. D., Ahern G. L., et al. (1997) Neuroanatomical correlates of externally and internally generated human emotion. Am. J. Psychiatry 154,918-925.
189. Renner K. and Luine V. (1986) Analysis of temporal and dose-dependent effects of estrogen on monoamines in brain nuclei. Brain Res. 366,64-71.
190. Renner K. J., Biegen A., and Luine V. N. (1985) Sex differences in long-term gonadectomized rats: monoamine levels and [3H]nitroimipramine binding in brain nuclei. Exp. Brain Res. 58,198-201.
191. Renner K. J., Krey L. C, and Luine V. N. (1987) Effect of progesterone on monoamine turnover in the brain of the estrogen-primed rat. Brain Res. Bull. 19,195-202.
192. Renner K., Allen D. L., and Luine V. (1986) Monoamine levels and turnover in brain: relationship to priming actions of estrogen. Brain. Res. Bull. 16,469-75.
193. Ribeiro R. C, Kushner P. J., and Baxter J. D. (1995) The nuclear hormone receptor gene superfamily. Ann. Rev. Med. 46,443-453.
194. Richards J. G., Saura J., Ulrich J., and Da Prada M. (1992) Molecular neuroanatomy of monoamine oxidases in human brainstem. Psychopharmacology 106, S21-S23.
195. Rickels K., Freeman E. W., Sondheimer S., and Albert J. (1990) Fluoxetine in the treatment of premenstual syndrome. Cnrr. Tlier. Res. 48, 161-166.
196. Rittenhouse P. A., Levy A. D., Li Q., Bethea C. L., and Van de Kar L. D. (1993) Neurons in the hypothalamic paraventricular nucleus mediate the serotonin stimulus of prolactin secretion via 5HT1C/2 receptors. Endocrinology 133,661-667.
197. Rojansky N., Halbreich U., Zander K., Barkai A., and Goldstein S. (1991) Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol. Obstet. Invest. 31,146-152.
198. Romano G. J., Krust A., and Pfaff D. W. (1989) Expression and estrogen regulation of progesterone receptor mRNA in neurons of the mediobasal hypothalamus: an in situ hybridization study. Mol. Endocrinol. 3,1295-1300.
199. Rubinow D. R. and Schmidt P. J. (1995) The treatment of premenstrual syndrome-forward into the past. N. Engl. J. Med. 332,1574-1575.
200. Sar M. and Stumpf W. A. (1981) Central noradrenergic neurons concentrate [3H]-oestradiol. Nature 289, 500-502.
201. Saura J., Kettler R., Da Prada M., and Richards J. G. (1982) Quantitative enzyme radioautography with [3H]-Ro 41-1049 and [3H]-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J. Neurosci. 12,1977-1999.
202. Schneider L. S., Small G. W., Hamilton S. H., Bystritsky A., Nemeroff C. B., and Meyers B. S. (1997) Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Am. J. Geriat. Psych. 5,97-106.
203. Schumacher M., Coirini H. and McEwen B. S. (1989) Regulation of high-affinity GABA-A receptors in specific brain regions by ovarian hormones. Nenroendocrinology 50,315-320.
204. Schutzer W. E. and Bethea C. L. (1997) Lack of ovarian steroid hormone regulation of norepinephrine transporter mRNA expression in the non-human primate locus coeruleus. Psychoncuroendocrinology 22,325-336.
205. Schutzer W. Ev Widmann A. A., and Bethea C. L. (1997) Effect of estrogen (E) and progesterone (P) on CSF concentrations of biogenic amines in pigtail macaques. Soc. Neuros. 23, 2039, Abstract 793.18.
206. Sharp T., McQuade R., Bramwell S., and Hjorth S. (1993) Effect of acute and repeated administration of 5HT1A receptor agonists on 5HT release in rat brain in vivo. Nmini/n-Schmiedebergs Arch. Pharmacol. 348,339-346.
207. Shenvin B. B. (1991) The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J. Clin. Endocrinol. Metab. 72,336-343.
208. Shenvin B. B. (1996) Menopause, early aging and elderly women, in PsycJiopliarmncology and Women: Sex, Gender and Hormones, (Jensvold M. E, Halbreich U., and Hamiltion J. A., eds.) American Psychiatric Press, Washington, DC, pp. 225-240.
209. Sherwin B. B. and Gelfand M. M. (1989) A prospective one-year study of estrogen and progestin in postmenopausal women: effects on clinical symptoms and lipoprotein lipids. Obstet. Gynecol. 73, 759-766.
210. Sherwin B. B. and Suranyi-Cadotte B. E. (1990) Upregulatory effect of estrogen on platelet [3H]imipramine binding sites in surgically menopausal women. Biol. Psychiatry 28,339-348.
211. Shimizu H. and Bray G. (1993) Effects of castration, estrogen replacement and estrus cycle on monoamine metabolism in the nucleus accumbens measured by microdialysis. Brain Res. 621, 200-206.
212. Shughrue P. J., Komm B., and Merchenthaler I. (1996) The distribution of estrogen receptor-ß mRNA in the rat hypothalamus. Steroids 61, 678-681.
213. Shughrue P. J., Lane M. V., and Merchenthaler I. (1997a) Comparative distribution of estrogen
214. receptor-a and -ß mRNA in the rat central nervous system. J. Comp. Nenrol. 388,507-525.
215. Shughrue P., Scrimo P., Lane M., Askew R., and Merchenthaler I. (1997b) The distribution of estrogen receptor-ß mRNA in forebrain regions of the estrogen receptor-a knockout mouse. Endocrinology 138,5649-5652.
216. Shughrue P. J., Lubahn D. B., Negro-Vilar A., Korach K. S., and Merchenthaler I. (1997c) Responses in the brain of estrogen receptor a-disrupted mice. Proc. Natl. Acad. Sei. USA 94, 11,008-11,012.
217. Shughrue P. J., Sar M., and Stumpf W. E. (1992) Progestin target cell distribution in forebrain and midbrain regions of the 8-day postnatal mouse / brain. Endocrinology 130,3650-3659.
218. Siever L. J., Kahn R. S., Lawlor B. A., Trestman R. L., Lawrence T. L., and Coccaro E. F. (1991) II. Critical issues in defining the role of serotonin in psychiatric disorders. Pharmacol. Rev. 43, 509-525.
219. Simerly R. B. (1993) Distribution and regulation of steroid hormone receptor gene expression in the central nervous system, in Advances in Neurology (Seil F. J., ed.), Raven, New York, pp. 207-225.
220. Simerly R. B., Chang C., Muramatsu M., and Swanson L. W. (1990) Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neural. 294,76-95.
221. Sinclair-Worley L., Maswood S., Conrad-Webb H., Rudick M., and Uphouse L. (1997) Effects of estradiol benzoate on 5HT1A receptor mRNA in the mediobasal hypothalamus of female rats. Soc. Neurosci. 23,1222, Abstract 484.2.
222. Singh A. and Lucki I. (1993) Antidepressant-like activity of compounds with varying efficacy at 5HT1A receptors. Ncuropliarmacology 32,331-340.
223. Skinner K., Fields H. L., Basbaum A. I., and Mason P. (1997) GABA-immunoreactive boutons contact identified OFF and ON cells in the nucleus raphe magnus. J. Comp. Nenrol. 378,196-204.
224. Sprouse J. S. and Aghajanian G. K. (1986) (-)Propanolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5HT1A selective agonists. Enr. J. Pharmacol. 128, 295-298.
225. Steinbusch H. W. M. (1981) Distribution of serotonin-immunoreactivity in thé central nervous system of the rat-cell bodies and terminals. Neuroscience 6,557-618.
226. Steinbusch H. W. M. and Nieuwenhuys R. (1983) The raphe nuclei of the rat brainstem: A cytoarchitectural and immunohistochemical study, in Chemical Neuroanatomy (Emson P. C. ed.), Raven, New York, p. 131-207.
227. Steiner M. (1996) Premenstrual dysphoric disorder, an update. Gen. Has. Psychiatry 18,244-250.
228. Steiner M., Steinber S., Stewart D., et al, (1995) Fluoxetine in the treatment of premenstrual dysphoria. N. Engl. J. Med. 332,1529-1534.
229. Steriade M. (1996) Arousal: revisiting the reticular activating system. Science 272, 225-226.
230. Sterling R. J., Case J. M., Sharp P. J., Renoir J. M., Tuohimaa P., and Baulieu E. E. (1987) The distribution of nuclear progesterone receptor in the hypothalamus and forebrain of the domestic hen. Cell. Tissue Res. 248,201-205.
231. Stewart D. F. and Boydell K. M. (1993) Psychologic distress during menopause: associations across the reproductive life cycle. Int. J. Psychiatry Med. 23,157-162.
232. Stone A. B., Pearlstein T. B., and Brown W. A. (1990) Fluoxetine in the treatment of premenstrual syndrome. Psychopharniacol. Bull. 26,331-335.
233. Su T. P., Schmidt P. J., Danaceau M., Murphy D. L., and Rubinow D. R. (1997) Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist mchlorophenylpiperazine in women with premenstrual syndrome and controls. J. Clin. Endocrinol. Metab. 82,1220-1228.
234. Summer B. E. H. and Fink G. (1993) Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain. Mol Cell. Neurosci. 4,83-92.
235. Summer B. E. H. and Fink G. (1995) Estrogen increases the density of 5-hydroxytryptamine 2A receptors in the cerebral cortex and nucleus accumbens in the female rat. J. Steroid Eiochem. Mol. Biol. 54,15-20.
236. Summer B. E. H. and Fink G. (1997) The density of 5-hydroxytryptamine 2A receptors in forebrain is increased at pro-oestrus in intact female rats. Neurosci. Lett. 234,7-10.
237. Sundblad C., Hedberg M. A., and Eriksson E. (1993) Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsyclwplmrinacology 9,133-145.
238. Tanaka E., Baba N., Toshida K., and Suzuki K. (1993) Evidence for 5HT2 receptor involvement in the stimulation of preovulatory LH and prolactin release and ovulation in normal cycling rats. Life Sei. 52, 669-676.
239. Tanco S. A., Watson N. V., and Gorzalka B. B. (1993) Lack of effects of 5-HT3 antagonists on normal
240. and morphine-attenuated sexual behaviors in female and male rats. Experientia 49,238-241.
241. Tanco S. A., Watson N. V., and Gorzalka B. B. (1994) Effects of 5-HT3 agonists on reproductive behaviors in rats. Psychopharmacology 115,245-248.
242. Tork I. (1985) Raphe nuclei and serotonin containing systems, in The Rat Nervous System (Paxinos G., ed.), Academic, Sydney, Australia, p. 43-78.
243. Tork I. and Hornung J. P. (1990) Raphe nuclei and the serotonergic system, in The Human Nervous System (Paxinos G. ed.), Academic, San Diego, p. 1001-1022.
244. Travis K. A., Bockholt H. J., Zardetto-Smith A. M., and Johnson A. K. (1995) In vitro thermosensitivity of the midline thalamus. Brain Res. 686,17-22.
245. Tremblay G. B., Tremblay A., Copeland N. G., et al. (1997) Cloning, chromosomal localization and functional analysis of the murine estrogen receptor beta. Mol. Endocrinol, 11,353-365.
246. Tsai M. J. and O'Malley R. W. (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Anna. Rev. Biocliem. 63, 451-486.
247. Tulving E., Markowitsch H. J., Kapur S., Habib R., and Houle S. (1994) Novelty encoding networks in the human brain: positron emission tomography data. Neuro Report 5,2525-2528.
248. Ulrich U., Novvara L, and Rossmanith W. G. (1994) Serotoninergic control of gonadotrophin and prolactin secretion in women. Clin. Endocrinol. 41, 779-785.
249. Uphouse L., Colon L., Cox A., Caldarola-Pastuszka M., and Wolf A. (1996) Effects of mianserin and ketanserin on lordosis behavior after systemic treatment or infusion into the ventromedial nucleus of the hypothalamus. Brain Res. 718, 46-52.
250. Valentino R. J., Foote S. L., and Page M. E. (1993) The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann. NY Acad. Sei. 697,173-188.
251. Van de Kar L. (1991) Neuroendocrine pharmacology of serotonergic (5HT) neurons. Ann. Rev. Phannacol. Toxicol 31,289-320.
252. Van de Kar L. D., Rittenhouse P. A., Li Q., and Levy A. D. (1996) Serotonergic regulation of renin and prolactin secretion. Behav. Brain Res. 73,203-208.
253. Vasko M. R., Pang I. H., and Vogt M. (1984) Involvement of 5-hydroxytryptamine-containing neurons in antinociception produced by injection of morphine into nucleus raphe magnus or onto spinal cord. Brain Res. 306,341-348.
254. Von Korff R. W. (1979) Monoamine Oxidase: Structure Function and Altered Functions, Academic, New York, pp. 1-7.
255. Wagner J. D., Martino M. A., Jayo M. J., Anthony M. S., Clarkson T. B., and Cefalu W. T. (1996) The effects of hormone replacement therapy on carbohydrate metabolism and cardiovascular risk factors in surgically postmenopausal cynomolgus monkeys. Metab. Clin. Exp. 45,1254-1262.
256. Wakerley J. B., Jiang Q. B., Housham S. J., Terenzi M. G., and Ingram C. D. (1995) Influence of reproductive state and ovarian steroids on facilitation of the milk-ejection reflex by central oxytocin. Adv. Exp. Med. Biol. 395,117-132.
257. Walker R. R and Wilson C. A. (1983) Changes in hypothalamic serotonin associated with amplification of LH surges by progesterone in rats. Neuroendocrinologi/ 37,200-205.
258. Wang Q-.P. and Nakai Y. (1994) The dorsal raphe nucleus: an important nucleus in pain modulation. Brain. Res. Bull. 34,575-585.
259. Wang R. Y. and Aghajanian G. K. (1977) Physiological evidence for habenula as major link between forebrain and midbrain raphe. Science 197, 89-91.
260. Warembourg M., Jolivet A., and Milgrom E. (1989) Immunohistochemical evidence of the presence of estrogen and progesterone receptors in the same neurons of the guinea pig hypothalamus and preoptic area. Brain Res. 480,1-15.
261. Webb P., Lopez G. N., Uht P. M., and Kushner P. J. (1995) Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9,443-56.
262. Weiss G. K., Ratner A., Voltura A., Savage D., Lucero K., and Castillo N. (1994) The effect of two different types of stress on locus -coeruleus alpha-2 receptor binding. Brain Res. Bull. 33,219-221.
263. Weiss J. M., Stout J. C., Aaron M. F., et al. (1994) Depression and anxiety: role of the locus coeruleus and corticotropin releasing factor. Brain Res. Bull. 35,561-572.
264. Weissman M. M. and Klerman G. L. (1985) Gender and depression. Trends Neurosci. 8,416-420.
265. Weissman M. M. and Olfson M. (1995) Depression in women: implications for health care research. Science 269, 799-808.
266. Westlund K. N., Denney R. M., Kochersperger L. M., Rose M., and Abell C. W. (1985) Distinct monoamine oxidase A and B populations in primate brain. Science 230,181-182.
267. Westlund K. N., Denney R. M., Rose R. M., and Abell C. W. (1988) Localization of distinct
268. monoamine oxidase A and monoamine oxidase B cell populations in human brain stem. Neuroscience 25,439-456.
269. Williams J. B. W., Spitzer R. L., Linzer M., et al. (1995) Gender differences in depression in primary Care. Am. J. Obstet. Gynecol. 173, 654-659.
270. Wirz-Justice A., Hackmann E., and Lichtsteiner M. (1974) The effect of oestradiol dipropionate and progesterone on monoamine uptake in rat brain. J. Ncuwchem. 22,187-189.
271. Wissink S., van Heerde E. C, van der Burg B., and van der Saag P. T. (1998) A dual mechanism mediates repression of NF-KB activity by glucocorticoids. Mol. Endocrinol. 12,355-363.
272. Wolf W. A. and Schutz L. J. (1997) The serotonin 5, ' HT2C receptor is a prominent serotonin receptor in basal ganglia: Evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis. J. Neiirocliem. 69,1449-1458.
273. Wright D. E., Seroogy K. B., Lunfergren K. H., Davis B. M., and Jennes L. (1995) Comparitive localization of serotonin 1A, 1C and 2 receptor subtype mRNA in rat brain. J. Comp. Nenrol 351,357-373.
274. Yatham L. N. (1993) Is 5HT1A receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study. Can. J. Psych. 38,662-664.
275. Yen P. M. (1996) Dominant negative activity by estrogen and progesterone receptors, in Estrogens, Progestins and Their Antagonists, vol. 2, (Pavlik E. J., ed.), Birkhauser, Boston, pp. 153-168.
276. Yonkers K. A., Gullion C., Williams A., Novak K., and Rush A. J. (1996a) Paroxetine as a treatment for premenstrual dysphoric disorder. J. Clin. Psyclwpliarinncol. 16,3-8.
277. Yonkers K. A., Halbreich U., Freeman E., Brown C., and Pearlstein T. (1996b) Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharnmcol. Bull. 32,41-46.
278. Yonkers K. A., Halbreich U., Freeman E., et al. (1997) Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline premenstrual dysphoric collaborative study group. JAMA 278,983-988.
279. Youdim M. B. H. and Finberg J. P. M. (1991) New directions in monoamine oxidase A and B selective inhibitors and substrates. Biochem. Phannacol. 41,155-162.
280. Zahm D. S. and Brog J. S. (1992) On the significance of subterritories in the accumbens part of the rat ventral straitum. Nenroscience 50,751-767.